CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
- Tax period
- 2023-01-01 to 2023-12-31
- Filed
- 2024-11-15
- IRS object ID
- 202403209349300045
- Schema version
- 2023v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-11-15T02:30:30-06:00 | ReturnTs |
| Tax Period End | 2023-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 221478099 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | COHNREZNICK LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7501 WISCONSIN AVENUE SUITE 400E | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2023-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 311667995 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CONQUER CANCER FOUNDATION OF THE | BusinessNameLine1Txt |
| Business Name Line2 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | CONQ | BusinessNameControlTxt |
| Phone | 5714831700 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MELINDA O'LEARY | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 5714831700 | PhoneNum |
| Signature | 2024-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | LORI ROTHE YOKOBOSKY CPA | PreparerPersonNm |
| PTIN | P01273422 | PTIN |
| Phone | 3016529100 | PhoneNum |
| Preparation | 2024-11-13 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2024-10-15 13:58:12Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CONQUER CANCER & CONQUER CANCER FDTN | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | NANCY DALY MS MPH | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $45,995,246 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.CONQUER.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1999 | FormationYr |
| Legal Domicile State | VA | LegalDomicileStateCd |
| Activity Or Mission | TO ACCELERATE BREAKTHROUGHS IN LIFESAVING RESEARCH AND EMPOWER PEOPLE EVERYWHERE TO CONQUER CANCER. | ActivityOrMissionDesc |
| Voting Members Governing Body | 21 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 20 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 300 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $31,125,188 | PYContributionsGrantsAmt |
| CY Contributions Grants | $34,540,916 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $363,476 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,328,134 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,837,688 | PYInvestmentIncomeAmt |
| CY Investment Income | $3,429,291 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$192,660 | PYOtherRevenueAmt |
| CY Other Revenue | -$201,634 | CYOtherRevenueAmt |
| PY Total Revenue | $33,133,692 | PYTotalRevenueAmt |
| CY Total Revenue | $39,096,707 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $20,648,632 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $19,433,873 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $0 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $0 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $257,693 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $358,751 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $7,307,153 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $11,982,603 | PYOtherExpensesAmt |
| CY Other Expenses | $13,783,056 | CYOtherExpensesAmt |
| PY Total Expenses | $32,888,928 | PYTotalExpensesAmt |
| CY Total Expenses | $33,575,680 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $244,764 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $5,521,027 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $98,117,170 | TotalAssetsBOYAmt |
| Total Assets EOY | $110,051,603 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $14,432,042 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $13,025,732 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $83,685,128 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $97,025,871 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | CONQUER CANCER FUNDS RESEARCH FOR EVERY TYPE OF CANCER TO BENEFIT EVERY PATIENT, EVERYWHERE. WORKING IN COLLABORATION WITH A GLOBAL NETWORK OF TOP SCIENTISTS AND CLINICIANS, AND LEADING ADVOCACY AND RESEARCH ORGANIZATIONS, CONQUER CANCER DRAWS (CONTINUED IN SCHEDULE O) ON THE PASSION AND EXPERTISE OF THE CANCER PROFESSIONALS WHO ARE MEMBERS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO). CONQUER CANCER WORKS TO HELP CREATE A WORLD WHERE CANCER IS PREVENTED OR CURED AND EVERY SURVIVOR IS HEALTHY. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $16,665,053 | ExpenseAmt |
| Grant | $12,041,145 | GrantAmt |
| Desc | SEE SCHEDULE O:RESEARCH: RESEARCH IS HOW WE CONQUER CANCER. IT MEANS EVERYTHING, FROM UNDERSTANDING HOW CANCER IMPACTS CERTAIN PEOPLE TO FINDING GROUNDBREAKING NEW WAYS TO TREAT CANCER. THE CONQUER CANCER GRANTS & AWARDS PROGRAM HAS BEEN RECOGNIZING EXCELLENCE IN CLINICAL RESEARCH, QUALITY CARE, AND TEACHING IN THE FIELD OF ONCOLOGY SINCE 1984, WHEN THE PROGRAM ORIGINALLY BEGAN UNDER THE PURVIEW OF ASCO. CONQUER CANCER FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. CONQUER CANCER AND ASCO HAVE FUNDED MORE THAN $190 MILLION TO SUPPORT GRANTS & AWARDS TO OVER 9,200 RECIPIENTS IN 89 COUNTRIES.HIGHLIGHTS OF 2023 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE: *ADVANCED CLINICAL RESEARCH AWARD (ACRA): $1,350,000 PROVIDED THREE (3) THREE-YEAR AWARDS TO SUPPORT PHYSICIAN-SCIENTISTS COMMITTED TO PERFORMING ORIGINAL, CLINICAL CANCER RESEARCH WITH A PATIENT-ORIENTED FOCUS. TWO AWARDS SUPPORTED DIVERSITY/INCLUSION, FOCUSING ON BREAST CANCER AND ONE AWARD FOCUSED ON TRIPLE-NEGATIVE BREAST CANCER.*CAREER DEVELOPMENT AWARD (CDA): $4,200,000 PROVIDED TWENTY-ONE (21) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS.*YOUNG INVESTIGATOR AWARD (YIA): $4,550,000 PROVIDED NINETY-ONE (91) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT.*GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD: $250,000 PROVIDED FIVE (5) ONE-YEAR AWARDS TO EARLY-CAREER INVESTIGATORS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN GLOBAL ONCOLOGY AND TO DEVELOP THE NEXT GENERATION OF RESEARCHERS TO ADDRESS GLOBAL HEALTH NEEDS.THIS IS A MENTORED AWARD AND THE RESEARCH PROJECT IS CONDUCTED UNDER THE GUIDANCE OF A SCIENTIFIC MENTOR.*INTERNATIONAL INNOVATION GRANT: $100,000 PROVIDED FIVE (5) ONE-YEAR AWARDS IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT HAVE THE POTENTIAL TO REDUCE THE CANCER BURDEN IN LOCAL COMMUNITIES, WHILE ALSO BEING POTENTIALLY TRANSFERRABLE TO OTHER LOW- OR MIDDLE- INCOME SETTINGS.THROUGH ITS EVERYGRANT PROGRAM, CONQUER CANCER UTILIZES OUR SKILLS AND EXPERTISE IN GRANTS ADMINISTRATION AND PROGRAM MANAGEMENT TO COLLABORATE WITH OTHER ORGANIZATIONS TO DEVELOP AND DELIVER PROGRAMS THAT MAKE A DIFFERENCE TO CANCER CARE TEAMS AND PATIENTS EVERYWHERE. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $6,151,814 | ExpenseAmt |
| Grant | $5,955,643 | GrantAmt |
| Desc | SEE SCHEDULE O:PROFESSIONAL EDUCATION: CONQUER CANCER SUPPORTS THE EFFORTS OF ASCO TO PROVIDE EDUCATION PROGRAMS IN THE US AND INTERNATIONALLY WHICH PROMOTE THE VITAL EXCHANGE OF IDEAS AND LATEST DEVELOPMENTS THAT LEAD TO WORLD-CLASS CARE, EVERYWHERE. FUNDS FROM CONQUER CANCER ARE USED TO SUPPORT ASCO'S SCIENTIFIC AND EDUCATIONAL PROGRAMS THROUGH BOTH MEETINGS AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC PROGRAMS SUPPORTED BY CONQUER CANCER AND PRESENTED TO THE PUBLIC IN 2023 INCLUDE THE FOLLOWING:* ASCO ANNUAL MEETING: THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY WITH MORE THAN 44,000 PARTICIPANTS WORLDWIDE IN 2023. THE ANNUAL MEETING PROVIDES A FORUM TO JOIN GLOBAL CANCER EXPERTS AND DISCOVER THE LATEST INNOVATIONS IN CANCER RESEARCH AND EDUCATION WHILE ADDRESSING THE NEED FOR EVERY PATIENT TO RECEIVE THE HIGHEST QUALITY AND EQUITABLE CANCER CARE AVAILABLE.*GASTROINTESTINAL CANCERS (GI) SYMPOSIUM: THIS IS THE PREMIER MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING. THE GI SYMPOSIUM GIVES HEALTHCARE PROVIDERS ACROSS MULTIPLE DISCIPLINES AND PROFESSIONS THE OPPORTUNITY TO RECEIVE CRITICAL UPDATES AND RECOMMENDATIONS TO IMPROVE THE CARE OF PATIENTS WITH GI CANCERS.*GENITOURINARY CANCERS (GU) SYMPOSIUM: THIS IS THE PREEMINENT GENITOURINARY ONCOLOGY EVENT, ADDRESSING THE MULTIDISCIPLINARY NEEDS OF PHYSICIANS AND OTHER MEMBERS OF THE CANCER CARE AND RESEARCH COMMUNITY WHO DIAGNOSE, TREAT, AND STUDY GENITOURINARY MALIGNANCIES. THE GU SYMPOSIUM PROVIDES THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS.*QUALITY CARE SYMPOSIUM: THIS IS AN UNPARALLELED OPPORTUNITY TO LEVERAGE THE MOST UP-TO-DATE SCIENCE AND DISCOVER PROVEN STRATEGIES AND TOOLS CRITICAL TO MAKING KEY DECISIONS THAT CAN REDUCE DISPARITIES IN CARE FOR EVERY PATIENT, EVERY DAY, EVERYWHERE.*MERIT AWARDS: $304,000 PROVIDED TWO HUNDRED NINETY-NINE (299) MERIT AWARDS PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AT ASCO SCIENTIFIC MEETINGS AND DISEASE SPECIFIC SYMPOSIA.*MEDICAL STUDENT ROTATION FOR UNDERREPRESENTED POPULATIONS (MSR): $212,500 PROVIDED TWENTY-FIVE (25) MEDICAL STUDENT ROTATIONS. THE MSR PROVIDES A 4-WEEK CLINICAL OR CLINICAL RESEARCH ROTATION FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,456,370 | ExpenseAmt |
| Grant | $1,437,086 | GrantAmt |
| Revenue | $1,328,134 | RevenueAmt |
| Desc | SEE SCHEDULE O:QUALITY & ACCESS TO CARE: REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CONQUER CANCER IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED.THROUGHOUT ASCO AND CONQUER CANCER'S HISTORY, THE ORGANIZATIONS HAVE STRIVED TO IMPROVE CARE FOR ALL PATIENTS WITH CANCER WHILE PAYING PARTICULAR ATTENTION TO THOSE MOST VULNERABLE. IN 2023, ASCO AND CONQUER CANCER CONTINUED WORK ON QUALITY AND EQUITABLE ACCESS TO CARE PROGRAMS THROUGH THEIR EQUITY, DIVERSITY AND INCLUSION INITIATIVE: ASCO AND CONQUER CANCER'S EQUITY, DIVERSITY AND INCLUSION INITIATIVE IS AMBITIOUS YET REALISTIC AND AIMS TO ADDRESS DISPARITIES AND WORK TOWARD ACHIEVING GREATER EQUITY IN CANCER CARE. PROGRAMS UNDER THIS INITIATIVE ADDRESS SUCH AREAS AS EDUCATION AND DIVERSIFICATION OF THE ONCOLOGY WORKFORCE AND SUPPORT FOR ONCOLOGISTS AND TRAINEES FROM UNDERREPRESENTED POPULATIONS IN MEDICINE; INCREASING PARTICIPATION BY DIVERSE POPULATIONS IN CLINICAL TRIALS; RESEARCH GRANTS IN DIVERSITY, INCLUSION, AND HEALTH DISPARITIES; PROVIDER TRAINING TO ADDRESS GAPS IN HEALTH DISPARITIES AND INCLUSION; AND ADDRESSING THE SPECIALIZED NEEDS OF POPULATIONS IN RURAL AREAS OF THE US. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $24,273,237 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (1) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | Yes (1) | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (1) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (1) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 282 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (1) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (1) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 21 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 20 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (1) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | 0 | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MELINDA O'LEARY | PersonNm |
| Phone | 5714831300 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD STE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt |
|---|---|---|---|---|---|---|---|
| CLIFFORD A HUDIS MD | |||||||
| EXECUTIVE VICE CHAIR | 6.50 | 31.00 | Yes (X) | Yes (X) | $0 | $1,060,801 | $24,750 |
| HOWARD A BURRIS III MD | |||||||
| BOARD CHAIR | 1.00 | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| AMY C PETERSON MD | |||||||
| SECRETARY | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| ALEXANDER W CASDIN | |||||||
| TREASURER | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| KATHRYN BEAL | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| WILLIAM BEHNKE | |||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| RICCARDO BRAGLIA | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| OTIS BRAWLEY MD | |||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| LAWRENCE H EINHORN MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| RAJ MANTENA RPH | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| THOMAS A MARSLAND MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ROBERT J MAYER MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| GERALD J MCDOUGALL | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ANNE MOORE MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| W CHARLES PENLEY MD | |||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| THOMAS G ROBERTS JR MD | |||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| STEVEN T ROSEN MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ALEXANDRA SHAPIRO | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| SANDRA SWAIN MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| MARGARET A TEMPERO MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| DEANNA B VAN GESTEL | |||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| LINDA JENSEN | |||||||
| CFO & EXECUTIVE VP | 1.00 | 36.50 | Yes (X) | $0 | $477,532 | $42,792 | |
| NANCY DALY MS MPH | |||||||
| CEO & EXECUTIVE VP | 36.50 | 1.00 | Yes (X) | $0 | $516,637 | $42,677 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $0 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $2,054,970 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $110,219 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (2 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| TRUE NORTH INC | |||||
| 12 WEST 27TH STREET 13TH FLOOR | NEW YORK | NY | 10001 | PRO FUNDRAISING SERVICES | $168,000 |
| THE HARRINGTON AGENCY | |||||
| 329 DICKINSON AVENUE | SWARTHMORE | PA | 19081 | PRO FUNDRAISING SERVICES | $127,500 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 2 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $2,923 | FederatedCampaignsAmt |
| Membership Dues | $1,136,500 | MembershipDuesAmt |
| Fundraising | $2,533,767 | FundraisingAmt |
| Related Organizations | $3,652,500 | RelatedOrganizationsAmt |
| Government Grants | $678,681 | GovernmentGrantsAmt |
| All Other Contributions | $26,536,545 | AllOtherContributionsAmt |
| Noncash Contributions | $459,764 | NoncashContributionsAmt |
| Total Contributions | $34,540,916 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | GRANTS EXPERTISE | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $1,328,134 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,328,134 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,328,134 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,573,994 | TotalRevenueColumnAmt |
| Exclusion | $2,573,994 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $7,552,202 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $6,696,905 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $855,297 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $855,297 | TotalRevenueColumnAmt |
| Exclusion | $855,297 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $2,533,767 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $201,634 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$201,634 | TotalRevenueColumnAmt |
| Exclusion | -$201,634 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $39,096,707 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,328,134 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $3,227,657 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,223,892 | TotalAmt |
| Program Services | $18,223,892 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $393,000 | TotalAmt |
| Program Services | $393,000 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $816,981 | TotalAmt |
| Program Services | $816,981 | ProgramServicesAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,910,924 | TotalAmt |
| Program Services | $2,888,058 | ProgramServicesAmt |
| Management And General | $1,453,334 | ManagementAndGeneralAmt |
| Fundraising | $4,569,532 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $45,600 | TotalAmt |
| Management And General | $45,600 | ManagementAndGeneralAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $358,751 | TotalAmt |
| Fundraising | $358,751 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,202 | TotalAmt |
| Management And General | $52,202 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,901,034 | TotalAmt |
| Program Services | $1,200,128 | ProgramServicesAmt |
| Management And General | $218,668 | ManagementAndGeneralAmt |
| Fundraising | $482,238 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $88,750 | TotalAmt |
| Fundraising | $88,750 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,142,478 | TotalAmt |
| Program Services | $133,119 | ProgramServicesAmt |
| Management And General | $92,442 | ManagementAndGeneralAmt |
| Fundraising | $916,917 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $819,814 | TotalAmt |
| Program Services | $128,249 | ProgramServicesAmt |
| Management And General | $94,160 | ManagementAndGeneralAmt |
| Fundraising | $597,405 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $158,678 | TotalAmt |
| Program Services | $158,550 | ProgramServicesAmt |
| Management And General | $128 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $531,135 | TotalAmt |
| Program Services | $324,014 | ProgramServicesAmt |
| Management And General | $38,756 | ManagementAndGeneralAmt |
| Fundraising | $168,365 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $132,441 | TotalAmt |
| Program Services | $7,246 | ProgramServicesAmt |
| Fundraising | $125,195 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,575,680 | TotalAmt |
| Program Services | $24,273,237 | ProgramServicesAmt |
| Management And General | $1,995,290 | ManagementAndGeneralAmt |
| Fundraising | $7,307,153 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,023,972 | BOYAmt |
| EOY | $5,985,305 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,402,813 | BOYAmt |
| EOY | $10,280,846 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $25,000 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $130,103 | BOYAmt |
| EOY | $85,000 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $83,560,282 | BOYAmt |
| EOY | $93,675,452 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $98,117,170 | BOYAmt |
| EOY | $110,051,603 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $160,281 | BOYAmt |
| EOY | $186,512 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,376,287 | BOYAmt |
| EOY | $6,724,249 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,179,628 | BOYAmt |
| EOY | $3,440,100 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,715,846 | BOYAmt |
| EOY | $2,674,871 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,432,042 | BOYAmt |
| EOY | $13,025,732 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,722,323 | BOYAmt |
| EOY | $37,868,738 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,962,805 | BOYAmt |
| EOY | $59,157,133 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $83,685,128 | BOYAmt |
| EOY | $97,025,871 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $98,117,170 | BOYAmt |
| EOY | $110,051,603 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $5,521,027 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $7,819,716 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $27,209,762 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $34,795,083 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $22,059,688 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $31,125,188 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $34,540,916 | CurrentTaxYearAmt |
| Total | $149,730,637 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $27,209,762 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $34,795,083 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $22,059,688 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $31,125,188 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $34,540,916 | CurrentTaxYearAmt |
| Total | $149,730,637 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $29,688,773 | SubstantialContributorsTotAmt |
| Public Support Total170 | $120,041,864 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,667,684 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,592,952 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,980,450 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,978,770 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,573,994 | CurrentTaxYearAmt |
| Total | $10,793,850 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $269,300 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $276,883 | CurrentTaxYearMinus3YearsAmt |
| Total | $546,183 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $106,173 | CurrentTaxYearMinus4YearsAmt |
| Total | $106,173 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $161,176,843 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $2,154,069 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.74480 | PublicSupportCY170Pct |
| Public Support PY170 | 0.81660 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $35,282,081 | BeginningYearBalanceAmt |
| Contributions | $6,649,346 | ContributionsAmt |
| Investment Earnings Or Losses | $4,658,864 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $1,470,639 | GrantsOrScholarshipsAmt |
| End Year Balance | $45,119,652 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $39,078,370 | BeginningYearBalanceAmt |
| Contributions | $2,822,771 | ContributionsAmt |
| Investment Earnings Or Losses | -$5,342,139 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $1,276,921 | GrantsOrScholarshipsAmt |
| End Year Balance | $35,282,081 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $35,692,561 | BeginningYearBalanceAmt |
| Contributions | $1,997,125 | ContributionsAmt |
| Investment Earnings Or Losses | $2,783,059 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $1,394,375 | GrantsOrScholarshipsAmt |
| End Year Balance | $39,078,370 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $27,740,161 | BeginningYearBalanceAmt |
| Contributions | $6,504,115 | ContributionsAmt |
| Investment Earnings Or Losses | $2,786,765 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $1,338,480 | GrantsOrScholarshipsAmt |
| End Year Balance | $35,692,561 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $17,571,755 | BeginningYearBalanceAmt |
| Contributions | $8,235,901 | ContributionsAmt |
| Investment Earnings Or Losses | $2,772,005 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $839,500 | GrantsOrScholarshipsAmt |
| End Year Balance | $27,740,161 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.00000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 1.00000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.00000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | DUE TO ASCO | Desc |
| Amt | $2,674,871 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,674,871 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $47,065,855 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $7,819,716 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | $7,819,716 | RevenueNotReportedAmt |
| Revenue Subtotal | $39,246,139 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $52,202 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | -$201,634 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$149,432 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $39,096,707 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $33,725,112 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $201,634 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $201,634 | ExpensesNotReportedAmt |
| Expenses Subtotal | $33,523,478 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $52,202 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $52,202 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $33,575,680 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, LINE 4: | PERMANENTLY RESTRICTED NET ASSETS OF DONOR-RESTRICTED ENDOWMENT FUNDS ARE PRESERVED, ABSENT EXPLICIT DIRECTION FROM THE DONOR. INTEREST FROM THE PERMANENTLY RESTRICTED FUNDS IS INTENDED TO FUND FUTURE RESEARCH AND/OR EDUCATIONAL AWARDS. |
| PART X, LINE 2: | CONQUER CANCER IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC"). IT HAS BEEN GRANTED PUBLIC CHARITY STATUS BY THE INTERNAL REVENUE SERVICE (THE "IRS") AND HAS BEEN CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. IN 2023 AND 2022, CONQUER CANCER GENERATED NO UNRELATED BUSINESS INCOME AND ACCORDINGLY HAD RELATED BUSINESS INCOME TAX OF $0 IN 2023 AND 2022, RESPECTIVELY. CONQUER CANCER ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). CONQUER CANCER BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. GENERALLY, CONQUER CANCER IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2020. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | FUNDRAISING EXPENSE -201,634. |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | FUNDRAISING EXPENSE 201,634. |
| PART XII, LINE 4B - OTHER ADJUSTMENTS: | FUNDRAISING EXPENSE |
| PART V, LINES 1A-AG | ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | PROGRAM SERVICES | AWARDS & GRANTS | $250,000 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | AWARDS & GRANTS | $190,000 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | AWARDS & GRANTS | $96,981 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | AWARDS & GRANTS | $190,000 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | AWARDS & GRANTS | $87,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $813,981 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $813,981 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (12 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| SOUTH ASIA | INTERNATIONAL INNOVATION GRANT (IIG) | $19,981 | WIRE | $0 |
| SOUTH ASIA | GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD (GO YIA) | $50,000 | WIRE | $0 |
| SUB-SAHARAN AFRICA | GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD (GO YIA) | $50,000 | WIRE | $0 |
| SOUTH ASIA | INTERNATIONAL INNOVATION GRANT (IIG) | $20,000 | WIRE | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | YOUNG INVESTIGATOR AWARD (YIA), CAREER PATHWAY GRANT IN SYMPTOM MANAGEMENT | $165,000 | WIRE | $0 |
| SUB-SAHARAN AFRICA | INTERNATIONAL INNOVATION GRANT (IIG) | $20,000 | WIRE | $0 |
| NORTH AMERICA | INTERNATIONAL INNOVATION GRANT (IIG) | $20,000 | WIRE | $0 |
| SUB-SAHARAN AFRICA | GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD (GO YIA) | $100,000 | WIRE | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | YOUNG INVESTIGATOR AWARD (YIA) | $50,000 | WIRE | $0 |
| SUB-SAHARAN AFRICA | INTERNATIONAL INNOVATION GRANT (IIG) | $20,000 | WIRE | $0 |
| EAST ASIA AND THE PACIFIC | YOUNG INVESTIGATOR AWARD (YIA) | $50,000 | WIRE | $0 |
| NORTH AMERICA | YOUNG INVESTIGATOR AWARD (YIA) | $150,000 | WIRE | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 12 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Foreign Individuals Grants ForeignIndividualsGrantsGrp (21 entries)
| Type Of AssistanceTypeOfAssistanceTxt | RegionRegionTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|---|
| ANNUAL MEETING MERIT AWARD | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU | 20 | $20,000 | WIRE |
| ANNUAL MEETING MERIT AWARD | NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 10 | $10,000 | WIRE |
| ANNUAL MEETING MERIT AWARD | EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 3 | $3,000 | WIRE |
| ANNUAL MEETING MERIT AWARD | MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 1 | $1,000 | WIRE |
| ANNUAL MEETING MERIT AWARD | SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 2 | $2,000 | WIRE |
| ANNUAL MEETING MERIT AWARD | SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, | 1 | $1,000 | WIRE |
| GASTROINTESTINAL CANCERS SYMPOSIUM MERIT AWARD | NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 2 | $2,000 | WIRE |
| GASTROINTESTINAL CANCERS SYMPOSIUM MERIT AWARD | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU | 4 | $4,000 | WIRE |
| GASTROINTESTINAL CANCERS SYMPOSIUM MERIT AWARD | SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 2 | $2,000 | WIRE |
| GENITOURINARY CANCERS SYMPOSIUM MERIT AWARD | NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 3 | $3,000 | WIRE |
| GENITOURINARY CANCERS SYMPOSIUM MERIT AWARD | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU | 6 | $6,000 | WIRE |
| QUALITY CARE SYMPOSIUM MERIT AWARD | EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 2 | $2,000 | WIRE |
| QUALITY CARE SYMPOSIUM MERIT AWARD | NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 2 | $2,000 | WIRE |
| BREAKTHROUGH MERIT AWARD | SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 2 | $2,000 | WIRE |
| BREAKTHROUGH MERIT AWARD | NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 3 | $3,000 | WIRE |
| BREAKTHROUGH MERIT AWARD | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU | 2 | $2,000 | WIRE |
| BREAKTHROUGH MERIT AWARD | EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 5 | $5,000 | WIRE |
| BREAKTHROUGH ABSTRACT AWARD | EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 27 | $27,000 | WIRE |
| BREAKTHROUGH ABSTRACT AWARD | MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 1 | $1,000 | WIRE |
| BREAKTHROUGH ABSTRACT AWARD | SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 1 | $1,000 | WIRE |
| BREAKTHROUGH ABSTRACT AWARD | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU | 3 | $3,000 | WIRE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | Yes (1) | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL EARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CONQUER CANCER REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CONQUER CANCER'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENT WITH THE APPROVED BUDGET. |
| PART I, LINE 3: | THE ACCRUAL METHOD IS USED TO ACCOUNT FOR FOREIGN EXPENDITURES. |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (1) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|---|---|---|---|
| TRUENORTH | ||||||||
| 515 MADISON AVE STE 8083 | NEW YORK | NY | 10022 | COUNSEL & MEDIA BUYS | 0 | $462,114 | $1,107,921 | -$645,807 |
| THE HARRINGTON AGENCY | ||||||||
| 329 DICKINSON AVENUE | SWARTHMORE | PA | 19081 | COUNSEL & MEDIA BUYS | 0 | $276,997 | $578,944 | -$301,947 |
| FAIRCOM NEW YORK | ||||||||
| 12 WEST 27TH ST 13TH FLOOR | NEW YORK | NY | 10001 | DIRECT MAIL SOLICITATIONS | 0 | $137,895 | $216,611 | -$78,716 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $877,006 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $1,903,476 | TotalRetainedByContractorsAmt |
| Total Net To Organization | -$1,026,470 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | INTEGRA CONNECT (OCTOBER) | Event1Nm |
| Gross Receipts Event1 | $1,468,251 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $1,468,251 | CharitableContriEvent1Amt |
| Event2 | CONQUER CANCER DINNER | Event2Nm |
| Gross Receipts Event2 | $674,193 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $674,193 | CharitableContriEvent2Amt |
| Food And Beverage Event2 | $86,373 | FoodAndBeverageEvent2Amt |
| Other Direct Expenses Event2 | $115,261 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 9 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $391,323 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $391,323 | CharitableContriOtherEventsAmt |
| Gross Receipts Total | $2,533,767 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $2,533,767 | CharitableContributionsTotAmt |
| Food And Beverage Total Events | $86,373 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $115,261 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $201,634 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$201,634 | NetIncomeSummaryAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE G, PART I, LINE 2B, COLUMN (V) | FormAndLineReferenceDesc |
| Explanation | CONQUER CANCER PAYS A RETAINER FEE FOR FUNDRAISING SERVICES, INCLUDING STRATEGY, COPY WRITING, LIST RECOMMENDATIONS, DATA ANALYSIS, ETC. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (39 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|
| CEDARS-SINAI MEDICAL CENTER | |||||||||
| 8700 BEVERLY BLVD 65-WILS 1150 | LOS ANGELES | CA | 90048 | 951644600 | 501(C)(3) | $250,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| CHILDREN'S HOSPITAL OF PHILADELPHIA | |||||||||
| 2716 SOUTH STREET | PHILADELPHIA | PA | 19146 | 231352166 | 501(C)(3) | $100,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| CITY OF HOPE | |||||||||
| 1500 E DUARTE ROAD | DUARTE | CA | 91010 | 953435919 | 501(C)(3) | $500,000 | $0 | ADVANCED CLINICAL RESEARCH AWARD, YOUNG INVESTIGATOR AWARD | |
| COLUMBIA UNIVERSITY | |||||||||
| 630 WEST 168TH STREET BOX 49 | NEW YORK | NY | 10032 | 135598093 | 501(C)(3) | $650,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| DANA-FARBER CANCER INSTITUTE | |||||||||
| 450 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042263040 | 501(C)(3) | $1,700,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD, ADVANCED CLINICAL RESEARCH AWARD | |
| EMORY UNIVERSITY | |||||||||
| 1599 CLIFTON ROAD 4TH FLOOR | ATLANTA | GA | 30322 | 580566256 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| GEORGETOWN UNIVERSITY MEDICAL CENTER | |||||||||
| 37TH O STREETS NW | WASHINGTON | DC | 20057 | 530196603 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE UNIVERSITY OF SOUTH FLOR | |||||||||
| 3702 SPECTRUM BLVD SUITE 165 | TAMPA | FL | 33612 | 593102112 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| HENRY FORD HEALTH | |||||||||
| 2799 WEST GRAND BLVD | DETROIT | MI | 482022689 | 381357020 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||
| 1 GUSTAVE L LEVY PLACE BOX 1075 | NEW YORK | NY | 10029 | 136171197 | 501(C)(3) | $100,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| JOHNS HOPKINS UNIVERSITY | |||||||||
| 733 N BROADWAY STE 117 | BALTIMORE | MD | 21205 | 520595110 | 501(C)(3) | $350,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 55 FRUIT STREET | BOSTON | MA | 02114 | 041564655 | 501(C)(3) | $165,000 | $0 | CAREER PATHWAY GRANTS IN SYMPTOM MANAGEMENT, YOUNG INVESTIGATOR AWARD | |
| MAYO CLINIC ARIZONA | |||||||||
| 13400 E SHEA BOULEVARD | SCOTTSDALE | AZ | 85259 | 860800150 | 501(C)(3) | $200,000 | $0 | CAREER DEVELOPMENT AWARD | |
| MAYO CLINIC MINNESOTA | |||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 559050001 | 416011702 | 501(C)(3) | $250,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| MEMORIAL SLOAN KETTERING CANCER CENTER | |||||||||
| 1275 YORK AVENUE | NEW YORK | NY | 10065 | 131624182 | 501(C)(3) | $1,500,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| NEW YORK UNIVERSITY (NYU) SCHOOL OF MEDICINE | |||||||||
| ONE PARK AVENUE 6TH FLOOR | NEW YORK | NY | 10016 | 135562308 | 501(C)(3) | $250,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| NORTHWESTERN UNIVERSITY | |||||||||
| 750 N LAKE SHORE DR RUBLOFF 7TH | CHICAGO | IL | 60611 | 362167817 | 501(C)(3) | $165,000 | $0 | YOUNG INVESTIGATOR AWARD, LONG-TERM INTERNATIONAL FELLOWSHIP | FLOOR |
| OHIO STATE UNIVERSITY | |||||||||
| 1960 KENNY RD | COLUMBUS | OH | 43210 | 316025986 | GOVT ENTITY | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| SEATTLE CHILDREN'S HOSPITAL | |||||||||
| 4800 SAND POINT WAY NE | SEATTLE | WA | 981053901 | 910564748 | 501(C)(3) | $100,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 38105 | 620646012 | 501(C)(3) | $50,000 | $0 | GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD | |
| STANFORD UNIVERSITY | |||||||||
| 455 BROADWAY ST | REDWOOD CITY | CA | 940633126 | 941156365 | 501(C)(3) | $250,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | |||||||||
| 1515 HOLCOMBE BOULEVARD | HOUSTON | TX | 770304009 | 760300816 | 501(C)(3) | $950,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| THOMAS JEFFERSON UNIVERSITY | |||||||||
| 833 CHESTNUT STREET SUITE 900 | PHILADELPHIA | PA | 19107 | 231352651 | 501(C)(3) | $200,000 | $0 | CAREER DEVELOPMENT AWARD | |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | |||||||||
| 1720 2ND AVENUE SOUTH | BIRMINGHAM | AL | 352940111 | 636005396 | 501(C)(3) | $200,000 | $0 | CAREER DEVELOPMENT AWARD | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||
| 490 ILLINOIS STREET 4TH FLOOR | SAN FRANCISCO | CA | 94143 | 946036493 | 501(C)(3) | $150,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| UNIVERSITY OF IOWA | |||||||||
| 100 GILMORE HALL | IOWA CITY | IA | 52242 | 426004813 | 501(C)(3) | $122,000 | $0 | CAREER PATHWAY GRANTS IN SYMPTOM MANAGEMENT | |
| UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE | |||||||||
| 1320 SOUTH DIXIE HWY | CORAL GABLES | FL | 33146 | 590624458 | 501(C)(3) | $250,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | |||||||||
| 104 AIRPORT DRIVE SUITE 2200 CAMPUS | CHAPEL HILL | NC | 275991350 | 566001393 | GOVT ENTITY | $350,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | BOX 1350 |
| UNIVERSITY OF PENNSYLVANIA | |||||||||
| 3451 WALNUT STREET 5TH FLOOR | PHILADELPHIA | PA | 191046205 | 231352685 | GOVT ENTITY | $150,000 | $0 | YOUNG INVESTIGATOR AWARD, GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP | FRANKLIN BUILDING |
| UNIVERSITY OF PITTSBURGH | |||||||||
| 300 MURDC 3420 FORBES AVENUE | PITTSBURGH | PA | 15260 | 250965591 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||||
| 3720 S FLOWER STREET CUB 303 | LOS ANGELES | CA | 90089 | 951642394 | GOVT ENTITY | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| UNIVERSITY OF UTAH | |||||||||
| 201 S PRESIDENTS CIRCLE RM 210 | SALT LAKE CITY | UT | 841128906 | 876000525 | 501(C)(3) | $200,000 | $0 | CAREER DEVELOPMENT AWARD | |
| UNIVERSITY OF WASHINGTON | |||||||||
| 4333 BROOKLYN AVENUE NE | SEATTLE | WA | 981959472 | 916001537 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||
| 3319 WEST END AVENUE SUITE 970 | NASHVILLE | TN | 37203 | 352528741 | 501(C)(3) | $50,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | |||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 131623978 | 501(C)(3) | $150,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| YALE UNIVERSITY | |||||||||
| 25 SCIENCE PARK 3RD FLOOR | NEW HAVEN | CT | 06511 | 060646973 | 501(C)(3) | $150,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||||
| 75 FRANCIS STREET | BOSTON | MA | 021156110 | 042312909 | 501(C)(3) | $250,000 | $0 | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | |
| AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | |||||||||
| 2318 MILL ROAD STE 800 | ALEXANDRIA | VA | 22314 | 136180380 | 501(C)(3) | $7,804,140 | $0 | CHARITABLE ASSISTANCE | |
| FRED HUTCHINSON CANCER CENTER | |||||||||
| 1100 FAIRVIEW AVE N | SEATTLE | WA | 98391 | 911935159 | 501(C)(3) | $100,000 | $0 | YOUNG INVESTIGATOR AWARD | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 39 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (3 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt |
|---|---|---|
| MERIT AWARDS | 185 | $188,000 |
| MEDICAL STUDENT ROTATION AWARDS | 25 | $190,000 |
| ANNUAL MEETING RESEARCH AWARDS | 10 | $15,000 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES AND SPONSORING INSTITUTIONS ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CONQUER CANCER AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT BY THE END OF THE PROJECT PERIOD OR TO MEET THE PROPOSED TIME SCHEDULES. CONQUER CANCER MAY APPROVE UP TO A MAXIMUM OF THREE NO-COST EXTENSIONS OF SIX MONTH INCREMENTS. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE THEIR SPONSORING INSTITUTION DURING THE COURSE OF THEIR GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (EXPENDITURE REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND AN EXPENDITURE REPORT ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF EACH GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, A FINAL PROGRESS REPORT AND A FINAL EXPENDITURE REPORT ARE REQUIRED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CONQUER CANCER. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROGRESS REPORT, FINAL EXPENDITURE REPORT, ANY REMAINING BALANCE ON THE GRANT, AND AFTER CONQUER CANCER'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS OF THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLIFFORD A HUDIS MD | ||||||||||||||
| EXECUTIVE VICE CHAIR | $0 | $1,049,613 | $0 | $10,000 | $0 | $1,188 | $0 | $24,750 | $0 | $0 | $0 | $1,085,551 | $0 | $0 |
| NANCY DALY MS MPH | ||||||||||||||
| CEO & EXECUTIVE VP | $0 | $504,351 | $0 | $10,000 | $0 | $2,286 | $0 | $24,750 | $0 | $17,927 | $0 | $559,314 | $0 | $0 |
| LINDA JENSEN | ||||||||||||||
| CFO & EXECUTIVE VP | $0 | $463,824 | $0 | $10,000 | $0 | $3,708 | $0 | $24,750 | $0 | $18,042 | $0 | $520,324 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 3 | FormAndLineReferenceDesc |
| Explanation | COMPENSATION IS ESTABLISHED BY A RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO). THE METHODS USED BY ASCO TO DETERMINE COMPENSATION ARE: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; FORMS 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY BOARD OR COMPENSATION COMMITTEE. | ExplanationTxt |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 17 | ContributionCnt |
| Noncash Contributions Rpt F990 | $459,764 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (1) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (B): | FormAndLineReferenceDesc |
| Explanation | THIS NUMBER REPRESENTS THE NUMBER OF CONTRIBUTIONS MADE, NOT THE NUMBER OF ITEMS CONTRIBUTED. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 7A | CONQUER CANCER DOES NOT HAVE MEMBERS. DIRECTORS OF CONQUER CANCER ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO. |
| FORM 990, PART VI, SECTION A, LINE 7B | THE BOARD OF DIRECTORS OF CONQUER CANCER MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CONQUER CANCER, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE. CONQUER CANCER MAY NOT AMEND ITS ARTICLES OF INCORPORATION WITHOUT PROVIDING TO ASCO WRITTEN NOTICE OF THE PROPOSED AMENDMENT AT LEAST THIRTY (30) DAYS IN ADVANCE. |
| FORM 990, PART VI, SECTION B, LINE 11B | A COPY OF THE TAX RETURN, INCLUDING ALL APPLICABLE SCHEDULES, WAS PROVIDED TO THE BOARD OF DIRECTORS, CHIEF FINANCIAL OFFICER AND GENERAL COUNSEL FOR REVIEW AND COMMENT PRIOR TO ITS FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | CONQUER CANCER MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CONQUER CANCER STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CONQUER CANCER'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS,CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CONQUER CANCER'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CONQUER CANCER IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CONQUER CANCER DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE CHIEF EXECUTIVE OFFICER OF CONQUER CANCER, THE EXECUTIVE VICE CHAIR OF CONQUER CANCER, AND THE CHIEF FINANCIAL OFFICER OF CONQUER CANCER SERVE AS EMPLOYEES OF ASCO. INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION, INCLUDING REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, ARE DESCRIBED IN THE IRS FORM 990 OF ASCO. CONQUER CANCER STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CONQUER CANCER. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO. CONQUER CANCER DOES NOT PAY COMPENSATION TO THESE INDIVIDUALS. |
| FORM 990, PART VI, SECTION C, LINE 19 | CONQUER CANCER'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CONQUER CANCER UPON REQUEST. CONQUER CANCER'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CONQUER CANCER'S WEBSITE. THE ANNUAL REPORT OF CONQUER CANCER IS POSTED ON CONQUER CANCER'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CONQUER CANCER UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CONQUER CANCER ARE POSTED ON CONQUER CANCER'S WEBSITE. |
| PART XII, LINE 2C | THE AUDIT OVERSIGHT PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Direct Controlling NADirectControllingNACd | Controlled OrganizationControlledOrganizationInd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMERICAN SOCIETY OF CLINICAL ONCOLOGY | |||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 136180380 | EDUCATION | NY | 501(C)(3) | LINE 10 | N/A | 0 | |
| ASCO ASSOCIATION | |||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 833561639 | MEMBER SERVICES | VA | 501(C)(6) | 0 | ASCO | ||
| ASCO ASSOCIATION PAC | |||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 844213157 | PAC | VA | 527 | 0 | ASCO ASSOCIATION | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (1) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (1) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (1) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASCO ASSOCIATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | Q | TransactionTypeTxt |
| Involved | $89,509 | InvolvedAmt |
| Method Of Amount Determination | COST | MethodOfAmountDeterminationTxt |